Veerix Biotech is a WHO-GMP certified third-party pharmaceutical manufacturer and CDMO partner producing VEERIX-RABEPRAZOLE Tablets (RABEPRAZOLE SODIUM IP ENTERIC COATED TABLET) within the Gastro Intestinal therapeutic class, with complete Certificate of Analysis (CoA), stability studies, and regulatory dossier compliance for domestic Indian and global export markets.
| Product Name | VEERIX-RABEPRAZOLE Tablets |
| Active Composition | RABEPRAZOLE SODIUM IP ENTERIC COATED TABLET |
| Therapeutic Segment | Gastro Intestinal |
| Dosage Form | Tablets |
| Primary Packaging | 10*10 Tablets |
| Quality Standard | IP / BP / USP Pharmacopeial Standard, WHO-GMP Certified |
| Manufacturing Facility | Tahliwal Industrial Area, Tehsil Haroli, Una, Himachal Pradesh & Coimbatore, Tamil Nadu |
| Regulatory Documentation | Batch Release CoA, Method of Analysis (MOA), Accelerated & Real-time Stability Data, CTD Module 3 |
Veerix Biotech provides end-to-end commercial supply and technical scoping for VEERIX-RABEPRAZOLE Tablets in the Gastro Intestinal class. From pre-formulation screening and pilot batch validation to automated blister packaging, serialisation, and multi-market regulatory clearance, our direct facilities and audited partner network ensure seamless execution.